Traditional CMV treatments, such as ganciclovir and valganciclovir, have notable limitations, including toxicity and bone ...

Zydus Lifesciences on Wednesday said it has launched ANVIMO, a breakthrough medication for the prevention of Cytomegalovirus ...

Zydus Lifesciences introduces ANVIMO (Letermovir) for CMV prevention in transplant patients, offering a safer, ...

Zydus Lifesciences announced that it has launch ANVIMO (Letermovir), a new and innovative treatment for the prevention of Cytomegalovirus (CMV) infection in hematopoietic stem cell transplant (HSCT) ...

In June 2024, Health Canada committed to publishing a list of drugs that are critical to patients and vulnerable to shortages. The list will help drug shortage stakeholders focus their actions and ...

Background: To observe and compare the efficacy of 2% ganciclovir eye drops in the treatment of Posner-Schlossman Syndrome relapses with/without cytomegalovirus intraocular reactivation. Methods: A ...